Characterization of First-Time Hospitalizations in Patients With Newly Diagnosed Pulmonary Arterial Hypertension in the REVEAL Registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of First-Time Hospitalizations in Patients With Newly Diagnosed Pulmonary Arterial Hypertension in the REVEAL Registry

Published:2014-11 Issue:5 Volume:146 Page:1263-1273
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Burger Charles D,Long Pamela K,Shah Monarch R,McGoon Michael D,Miller Dave P,Romero Alain J,Benton Wade W,Safford Robert E

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference20 articles.

1. Biomarkers and surrogate endpoints in clinical trials;Fleming;Stat Med,2012

2. Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension;Galiè;N Engl J Med,2005

3. Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial;Galiè;J Am Coll Cardiol,2002

4. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial;Galiè;Lancet,2008

5. Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study;Jing;Am J Respir Crit Care Med,2011

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review;ClinicoEconomics and Outcomes Research;2024-05

2. High-level clinical research promotes the development of risk stratification for pulmonary arterial hypertension;Chinese Science Bulletin;2023-12-01

3. Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH);PharmacoEconomics - Open;2023-11-18

4. Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension;Journal of Medical Economics;2023-10-31

5. Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH);Advances in Therapy;2023-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3